Aurinia Pharmaceuticals Newsroom

Insiders At Aurinia Pharmaceuticals Sold US$2.0m In Stock, Alluding To Potential Weakness

Simply Wall StNov 22 05:44 ET

Positive Outlook for Aurinia Pharmaceuticals Boosted by Favorable Lupus Nephritis Guidelines

TipRanksNov 21 01:17 ET

Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Siemens Healthineers AG (OtherSEMHF)

TipRanksNov 19 20:40 ET · Ratings

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

BusinesswireNov 18 17:53 ET

Express News | Aurinia Commends 2024 Updated Acr Guidelines for Screening, Treatment, and Management of Lupus Nephritis

ReutersNov 18 17:53 ET

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS in Managing LN at American College of Rheumatology Convergence 2024

BusinesswireNov 15 06:00 ET

Express News | Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of Lupkynis® in Managing Ln at American College of Rheumatology Convergence 2024

ReutersNov 15 06:00 ET

Aurinia to Participate in Jefferies London Healthcare Conference

BusinesswireNov 14 06:00 ET

RBC Capital Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Raises Target Price to $9

Moomoo NewsNov 11 07:31 ET · Ratings

Bloom Burton Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Raises Target Price to $10.85

Moomoo NewsNov 11 04:34 ET · Ratings

Positive Outlook on Aurinia Pharmaceuticals Amid Strong Financial Performance and Strategic Cost Management

TipRanksNov 11 03:35 ET

Leerink Partners Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating

Moomoo NewsNov 8 02:32 ET · Ratings

Aurinia Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Financial Results and Announced a Workforce Reduction.

BenzingaNov 7 12:18 ET

Aurinia Pharmaceuticals, Inc. (AUPH) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 7 11:47 ET · Conference Call

TD Cowen Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsNov 7 11:31 ET · Ratings

Aurinia Pharmaceuticals: Strong Growth Prospects Bolstered by Lupkynis Sales and Promising Pipeline

TipRanksNov 7 10:55 ET

Aurinia Pharmaceuticals Reports Strong Q3 Growth and Restructuring

TipRanksNov 7 06:37 ET

Aurinia Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 7 06:23 ET · Announcements

Aurinia Pharmaceuticals | 8-K: Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS ® Growth and AUR200 Development

SECNov 7 06:18 ET

Express News | Aurinia Pharmaceuticals Inc - to Reduce Workforce by Approximately 45% in Restructuring

ReutersNov 7 06:11 ET